Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
OBI Pharma Inc (4174 TT)
Watchlist
6
Analysis
Health Care
•
Taiwan
OBI Pharma Inc manufactures anti-infective and immunotherapy drugs and develops cancer and infectious disease therapies.
more
Watchlist
Filings
Presentations
Events
Refresh
Exchange Announcement •
02 May 2024 18:41
Announcement On Behalf Of Obigen That Tfda Clears Obi-858’S Ind Application For Phase Ii Human Clinical Trial
Attachment
Exchange Announcement •
25 Apr 2024 14:36
Announcement Of The Company’S Board Meeting Date To Approve 2024q1 Consolidated Financial Report
Attachment
Exchange Announcement •
12 Apr 2024 14:34
Announcement On Behalf Of Amaran Of Not Distributing Dividends Of 2023
Attachment
Exchange Announcement •
12 Apr 2024 14:33
Announcement On Behalf Of Amaran That The Bod Resolved To Convene The 2024 Annual General Shareholders' Meeting
Attachment
Exchange Announcement •
20 Mar 2024 17:11
Announcement On Behalf Of Obigen That The Bod Resolved To Issue 2024 Employee Stock Options And The Subscription Rules.
Attachment
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.31.1
x